- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Central Nervous System Malignancies
Total 135283 results
-
Bellicum PharmaceuticalsActive, not recruiting
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Leukemia | Plasma Cell Myeloma | Central Nervous System Lymphoma | Secondary Central Nervous System LymphomaUnited States
-
Wake Forest University Health SciencesCompletedLymphoma | LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingPleural Metastases | Thymic MalignanciesUnited States
-
Ying WangRecruiting
-
AbbVieRecruitingHematologic MalignanciesUnited States, Australia
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
Memorial Sloan Kettering Cancer CenterCompletedUnilateral Vocal Cord Paralysis | Intrathoracic MalignanciesUnited States
-
Oncternal Therapeutics, IncRecruitingRelapsed/Refractory Aggressive B-Cell MalignanciesUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
St. Jude Children's Research HospitalAssisi FoundationCompletedLymphoma | LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical Center; Brigham...CompletedHematologic MalignancyUnited States
-
University of California, San DiegoTerminated
-
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.Children's Hospital of Fudan UniversityUnknown
-
M.D. Anderson Cancer CenterJazz PharmaceuticalsWithdrawn
-
Roshni DasguptaRecruitingSolid Malignancies | Metastatic Disease | Primary TumorUnited States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced Malignancies That Harbor IDHR132 MutationsBelgium, Germany, Spain, Canada, Australia, United States, Netherlands, Singapore
-
University College, LondonCompletedCD19+ Malignancies: Relapse Post-allogeneic TransplantUnited Kingdom
-
AmgenCompletedCancer | Anemia | Non-Myeloid Malignancies
-
Medical University of ViennaCompleted
-
NYU Langone HealthWithdrawnCancer | Hematological MalignancyUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Seagen Inc.WithdrawnHematopoietic/Lymphoid CancerUnited States
-
Henan Cancer HospitalNanjing Bioheng Biotech Co., Ltd.Recruiting
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedHematological MalignanciesUnited States
-
Daiichi Sankyo, Inc.CompletedLymphoma | MalignanciesUnited States
-
He HuangGracell Biotechnology Ltd.Not yet recruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
AccentureCompletedHematologic MalignanciesKorea, Republic of, Australia, Canada
-
Bayside HealthThe Alfred; The Leukaemia Foundation of VictoriaUnknownRCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMTHematological MalignanciesAustralia
-
The Catholic University of KoreaUnknownHematologic MalignanciesKorea, Republic of
-
Nanfang Hospital of Southern Medical UniversityThe Seventh Affiliated Hospital of Sun Yat-sen University; The First People... and other collaboratorsRecruitingHematopoietic Stem Cell Transplantation | Hematological MalignanciesChina
-
First Affiliated Hospital of Zhejiang UniversityAffiliated Jinhua Hospital of Zhejiang UniversityCompletedHematological Malignancies | Haploidentical Stem Cell TransplantationChina
-
Grupo Espanol de trasplantes hematopoyeticos y...Unknown
-
St. James's Hospital, IrelandIrish Cancer SocietyCompletedHematological MalignanciesIreland
-
The University of Hong KongRecruitingPeritoneal MetastasesHong Kong
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Weill Medical College of Cornell UniversityActive, not recruitingTargeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord TransplantationHematologic MalignanciesUnited States
-
Karyopharm Therapeutics IncCompletedHematological MalignanciesUnited States, Denmark, Canada
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Mansoura UniversityCompletedHematological Malignancy (Leukemia- Lymphoma)Egypt
-
Jennifer AmengualAcetylon Pharmaceuticals IncorporatedCompletedLymphoma | Lymphoid MalignanciesUnited States
-
University of Michigan Rogel Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.Completed
-
M.D. Anderson Cancer CenterVion PharmaceuticalsCompletedHematologic MalignanciesUnited States
-
Fate TherapeuticsDana-Farber Cancer InstituteCompletedHematologic Malignancies | Allogeneic Stem Cell TransplantationUnited States
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI); National Institutes of Health (NIH)Withdrawn
-
M.D. Anderson Cancer CenterAccess Pharmaceuticals, Inc.Completed
-
Universidad Católica San Antonio de MurciaUnknownStem Cell Transplantation | Hematologic MalignancySpain
-
Sohag UniversityNot yet recruiting
-
IncuronTerminatedHematological MalignanciesUnited States
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Nonhematologic MalignanciesUnited States